These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7794369)

  • 1. Adverse effects of topical corticosteroid use.
    Fisher DA
    West J Med; 1995 Feb; 162(2):123-6. PubMed ID: 7794369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
    Semiz S; Balci YI; Ergin S; Candemir M; Polat A
    Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible side effects of topical steroids.
    Morman MR
    Am Fam Physician; 1981 Feb; 23(2):171-4. PubMed ID: 6450525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential new indications of topical calcineurin inhibitors.
    Luger T; Paul C
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids.
    Bewley A;
    Br J Dermatol; 2008 May; 158(5):917-20. PubMed ID: 18294314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of topical glucocorticosteroids.
    Hengge UR; Ruzicka T; Schwartz RA; Cork MJ
    J Am Acad Dermatol; 2006 Jan; 54(1):1-15; quiz 16-8. PubMed ID: 16384751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.
    Warshaw EM; Paller AS; Fowler JF; Zirwas MJ
    Clin Ther; 2008 Feb; 30(2):326-37. PubMed ID: 18343271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and abuse of topical corticosteroids in infections of the skin and related structures.
    Wong VK; Della Croce C; Schonfeld S; Mastrangelo AM; Lebwohl M
    J Drugs Dermatol; 2003 Jun; 2(3):268-76. PubMed ID: 12848111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema].
    Vestergaard L; Andersen KE
    Ugeskr Laeger; 1997 Sep; 159(38):5662-6. PubMed ID: 9340873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of corticosteroids.
    Goette DK; Odom RB
    Cutis; 1979 Apr; 23(4):477-87. PubMed ID: 154995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus in the management of atopic dermatitis in Japan.
    Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K
    Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
    Pariser D
    Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
    Brown KK; Rehmus WE; Kimball AB
    J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.